Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective
Andrew D Mihalek,1 Christopher D Scott,2 Sula Mazimba3 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, VA, USA; 2Division of Thoracic Surgery, Department of Surgery, University of Virginia, Charlottesville, VA, USA; 3Division of Car...
Main Authors: | Mihalek AD, Scott CD, Mazimba S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/evaluating-riociguat-in-the-treatment-of-pulmonary-arterial-hypertensi-peer-reviewed-fulltext-article-VHRM |
Similar Items
-
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
by: S. E. Gratsianskaya, et al.
Published: (2020-10-01) -
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
by: N. H. Kim
Published: (2010-03-01) -
Treatment of patients with chronic thrombo­embolic pulmonary hypertension: focus on riociguat
by: Smith ZR, et al.
Published: (2016-06-01) -
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
by: Vallerie V. McLaughlin, et al.
Published: (2017-12-01) -
Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
by: E. V. Filippov
Published: (2020-12-01)